Jin Medical International (ZJYL) Invested Capital (2022 - 2025)
Jin Medical International (ZJYL) has disclosed Invested Capital for 4 consecutive years, with $21.8 million as the latest value for Q3 2025.
- Quarterly Invested Capital fell 45.34% to $21.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $21.8 million through Sep 2025, down 45.34% year-over-year, with the annual reading at $21.8 million for FY2025, 45.34% down from the prior year.
- Invested Capital hit $21.8 million in Q3 2025 for Jin Medical International, down from $39.9 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $39.9 million in Q3 2024 to a low of $15.2 million in Q3 2022.
- Historically, Invested Capital has averaged $26.2 million across 4 years, with a median of $24.9 million in 2023.
- Biggest five-year swings in Invested Capital: soared 84.38% in 2023 and later crashed 45.34% in 2025.
- Year by year, Invested Capital stood at $15.2 million in 2022, then skyrocketed by 84.38% to $28.1 million in 2023, then surged by 41.94% to $39.9 million in 2024, then plummeted by 45.34% to $21.8 million in 2025.
- Business Quant data shows Invested Capital for ZJYL at $21.8 million in Q3 2025, $39.9 million in Q3 2024, and $28.1 million in Q3 2023.